Paul G. Kluetz
Paul G. Kluetz publishes mostly in Oncology, Surgery and Economics and Econometrics, on topics such as Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #205,313 of 1,633,909 ranked researchers
- Rank in United States
- #82,809 of 358,040
- Works
- 33
- Citations
- 133
- Citations per work
- 4.0
What does Paul G. Kluetz research?
Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.
- 1Oncology26% of their works
- 2Surgery17% of their works
- 3Economics and Econometrics17% of their works
- 4Pulmonary and Respiratory Medicine13% of their works
- 5Pediatrics, Perinatology and Child Health7% of their works
- 6Statistics and Probability6% of their works
Research topics
- Cancer Immunotherapy and Biomarkers
- Bladder and Urothelial Cancer Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Statistical Methods in Clinical Trials
- Lung Cancer Treatments and Mutations
- Cancer Treatment and Pharmacology
- Pharmaceutical studies and practices
Which keywords describe Paul G. Kluetz's research?
The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Quality of Life, Bladder Cancer, Urothelial Carcinoma, Clinical Trials, Cost-effectiveness Analysis and Health Utility Measures.
- Taxanes
- Off-Label Drug Use
- Targeted Therapy
- EGFR Mutations
- Financial Toxicity
- Health Utility Measures
- Clinical Trials
- Bladder Cancer
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Quality of Life
- Urothelial Carcinoma
- Cost-effectiveness Analysis
- Cost of Care
- Adaptive Designs
- False Discovery Rate
- Chemotherapy-Induced Peripheral Neuropathy
- Pediatric Pharmacokinetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Immune Checkpoint Blockade71 topic
- PD-1 and PD-L171 topic
- Quality of Life72 topics
- Bladder Cancer61 topic
- Urothelial Carcinoma61 topic
- Clinical Trials52 topics
- Cost-effectiveness Analysis51 topic
- Health Utility Measures51 topic
- Cost of Care41 topic
- Financial Toxicity41 topic
- Adaptive Designs31 topic
- EGFR Mutations31 topic
- False Discovery Rate31 topic
- Targeted Therapy31 topic
- Chemotherapy-Induced Peripheral Neuropathy21 topic
- Off-Label Drug Use21 topic
- Pediatric Pharmacokinetics21 topic
- Taxanes21 topic
Where does Paul G. Kluetz work?
Paul G. Kluetz's main affiliation in the publication record is United States Food and Drug Administration, United States.
How many publications and citations does Paul G. Kluetz have?
Science Explorer counts 33 works and 133 citations for Paul G. Kluetz, ranking #205,313 of 1,633,909 researchers worldwide on the composite score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.